Evaluation and application of the linear variable differential transformer technique for the assessment of human dorsal hand vein alpha-receptor activity
- 1 November 1985
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 38 (5) , 495-502
- https://doi.org/10.1038/clpt.1985.214
Abstract
Diurnal, day-to-day, intrasubject, and intersubject variability of responsiveness of dorsal hand veins to norepinephrine has been investigated by healthy young subjects through the use of a novel technique in which a linear variable differential transformer (LVDT) is placed directly over the vein. Under constant operating conditions, control vein diameter remained consistent. There is log dose responsiveness to norepinephrine infused directly into the hand vein. There was little diurnal, day-to-day, or intrasubject variability in the dose of norepinephrine required to induce 50% constriction of hand diameter. The responsiveness to norepinephrine of different veins in either hand was also consistent. However, there was wide intersubject variability, apparently unrelated to age, gender, or other subject characteristics. We conclude that the LVDT method is reproducible and reliable and offers a relatively noninvasive means of assessing the effects of disease and drugs on the human dorsal hand vein in vivo. The LVDT technique has been applied to study the rate of onset, magnitude of effect, dose responsiveness, and duration of action of intravenous dihydroergotamine, 0.1, 0.2, and 0.4 mg, on human dorsal hand veins. Despite systemic intravenous administration, there was an average delay in maximum response of 30 minutes to 1 hour. Venoconstriction was incomplete, with a maximum reduction of approximately 50% of vein diameter after each of the larger doses. There was no significant difference between the effects produced by 0.2 or 0.4 mg, which persisted for 6 hours after dosing.This publication has 4 references indexed in Scilit:
- Investigation of the venoconstrictor effect of 8? hydroxydihydroergotamine, the main metabolite of dihydroergotamine, in manEuropean Journal of Clinical Pharmacology, 1984
- Alpha-Adrenergic Hyper-Responsiveness in AsthmaNew England Journal of Medicine, 1979
- Forearm Venous Responses to Stimulation of Adrenergic Receptors*Journal of Clinical Investigation, 1965
- A TANDEM FOREARM PLETHYSMOGRAPH FOR STUDY OF ACUTE RESPONSES OF THE PERIPHERAL VEINS OF MAN: THE EFFECT OF ENVIRONMENTAL AND LOCAL TEMPERATURE CHANGE, AND THE EFFECT OF POOLING BLOOD IN THE EXTREMITIES1Journal of Clinical Investigation, 1958